MLchartDataset catalogue

NBI-3001

Term · Oncology and biomedicine · MLC-T-ONC-005699

A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. NBI-3001 is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL cytotoxin and interleukin-4 PE38KDEL immunotoxin.

Table 1. Record
IdentifierMLC-T-ONC-005699
FieldOncology and biomedicine
Expansionsinterleukin-4 PE38KDEL cytotoxin; interleukin-4 PE38KDEL immunotoxin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-005699",
  "term": "NBI-3001",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. It is made by combining interleukin-4 with a bacterial toxin. NBI-3001 is a type of recombinant chimeric protein. Also called interleukin-4 PE38KDEL cytotoxin and interleukin-4 PE38KDEL immunotoxin.",
  "expansions": [
    "interleukin-4 PE38KDEL cytotoxin",
    "interleukin-4 PE38KDEL immunotoxin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/nbi-3001/"
}

Record 11,637 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.